Cubist Systematic Strategies, LLC Trevena Inc Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.2 - $0.5 $3,024 - $7,560	15,121 New	15,121 $6,000
Q3 2021 Nov 15, 2021	SELL	$1.11 - $1.7 $119,658 - $183,260	-107,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.46 - $2.25 $258,260 - $398,004	-176,891 Reduced 62.13%	107,800 $182,000
Q1 2021 May 17, 2021	BUY	$1.77 - $2.93 $49,013 - $81,134	27,691 Added 10.77%	284,691 $510,000
Q4 2020 Feb 16, 2021	BUY	$2.13 - $3.26 $521,211 - $797,722	244,700 Added 1989.43%	257,000 $550,000
Q3 2020 Nov 16, 2020	SELL	$1.53 - $3.13 $22,950 - $46,950	-15,000 Reduced 54.95%	12,300 $37,000
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.75 $13,104 - $47,775	27,300 New	27,300 $41,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $3.47 $11,715 - $104,242	-30,041 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.39 - $2.25 $14,234 - $23,042	10,241 Added 51.72%	30,041 $64,000
Q2 2018 Aug 14, 2018	BUY	$1.44 - $2.24 $28,512 - $44,352	19,800 New	19,800 $29,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $273M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.